Skip to main content

Advertisement

Log in

Association between IgH enhancer hs1.2 and type 1 diabetes

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aim

To investigate the association of alleles of the 3′ immunoglobulin heavy-chain regulatory region 1 (3′RR-1) enhancer hs1.2 in patients with type 1 diabetes (T1D).

Methods

Eighty-one patients with T1D [among which 12 had concomitant coeliac disease (CD) and 25 an autoimmune thyroid disease (AITD)] were compared to 248 healthy individuals. All subjects were recruited from the same geographical area. Blood samples were collected from all patients and a nested PCR was performed to amplify the core of the 3′RR-1 and detect the alleles of the hs1.2 enhancer.

Results

Allele distribution in healthy individuals was significantly different when compared to that of patients with T1D (p < 0.01). Even greater differences were detected comparing allele distribution of patients with T1D alone versus those with concomitant CD, but not versus those with concomitant AITD. The frequency of *2 allele is increased by 23% in patients with T1D and CD.

Conclusions

The present study establishes that the multiallelic hs1.2 enhancer of the 3′RR-1 is associated with T1D, with higher frequency when there is co-occurrence of CD. This evidence has been previously observed in other immune diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Melchers F (2015) Checkpoints that control B cell development. J Clin Investig 125:2203–2210

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chatterjee S, Ju Z, Hassan R, Volpi SA, Emelyanov AV, Birshtein BK (2011) Dynamic changes in binding of immunoglobulin heavy chain 3′ regulatory region to protein factors during class switching. J Biol Chem 286:29303–29312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kim EC, Edmonston CR, Wu X, Schaffer A, Casali P (2004) The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3′ hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination. J Biol Chem 279:42258–42269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Birshtein BK (2014) Epigenetic regulation of individual modules of the immunoglobulin heavy chain locus 3′ regulatory region. Front Immunol 5:163

    Article  PubMed  PubMed Central  Google Scholar 

  5. Choi NM, Feeney AJ (2014) CTCF and ncRNA regulate the three-dimensional structure of antigen receptor loci to facilitate V(D)J recombination. Front Immunol 5:49

    Article  PubMed  PubMed Central  Google Scholar 

  6. Tang SJ (2016) The R-Operon: a model of repetitive DNA-organized transcriptional compartmentation of eukaryotic chromosomes for coordinated gene expression. Genes 7:16

    Article  PubMed Central  Google Scholar 

  7. D’Addabbo P, Scascitelli M, Giambra V, Rocchi M, Frezza D (2011) Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3′ regulatory region. BMC Evol Biol 11:71

    Article  PubMed  PubMed Central  Google Scholar 

  8. Mills FC, Harindranath N, Mitchell M, Max EE (1997) Enhancer complexes located downstream of both human immunoglobulin Cα genes. J Exp Med 186:845–858

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Giambra V, Fruscalzo A, Giufre M et al (2005) Evolution of human IgH3′EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor’s consensus sites. Gene 346:105–114

    Article  CAS  PubMed  Google Scholar 

  10. Birshtein BK, Chen C, Saleque S, Michaelson JS, Singh M, Little RD (1997) Murine and human 3′IgH regulatory sequences. Curr Top Microbiol Immunol 224:73–80

    CAS  PubMed  Google Scholar 

  11. Garot A, Marquet M, Saintamand A et al (2016) Sequential activation and distinct functions for distal and proximal modules within the IgH 3′ regulatory region. Proc Natl Acad Sci USA 113:1618–1623

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Le Noir S, Laffleur B, Carrion C et al (2017) The IgH locus 3′ cis-regulatory super-enhancer co-opts AID for allelic transvection. Oncotarget 8:12929–12940

    PubMed  PubMed Central  Google Scholar 

  13. Hewitt SL, Yin B, Ji Y et al (2009) RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci. Nat Immunol 10:655–664

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Holwerda SJ, van de Werken HJ, Ribeiro de Almeida C et al (2013) Allelic exclusion of the immunoglobulin heavy chain locus is independent of its nuclear localization in mature B cells. Nucleic Acids Res 41:6905–6916

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sette M, D’Addabbo P, Kelly G et al (2016) Evidence for a quadruplex structure in the polymorphic hs1.2 enhancer of the immunoglobulin heavy chain 3′ regulatory regions and its conservation in mammals. Biopolymers 105:768–778

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Serone E, Daleno C, Principi N et al (2014) The change in Ig regulation from children to adults disconnects the correlation with the 3′RR hs1.2 polymorphism. BMC Immunol 15:45

    Article  PubMed  PubMed Central  Google Scholar 

  17. Frezza D, Giambra V, Cianci R et al (2004) Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand J Gastroenterol 39:1083–1087

    Article  CAS  PubMed  Google Scholar 

  18. Frezza D, Giambra V, Tolusso B et al (2007) Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis 66:1210–1215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Frezza D, Tolusso B, Giambra V et al (2012) Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus. Ann Rheum Dis 71:1309–1315

    Article  CAS  PubMed  Google Scholar 

  20. Cianci R, Giambra V, Mattioli C et al (2008) Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol 128:1920–1924

    Article  CAS  PubMed  Google Scholar 

  21. Giambra V, Cianci R, Lolli S et al (2009) Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. J Immunol 183:8280–8285

    Article  CAS  PubMed  Google Scholar 

  22. Aupetit C, Drouet M, Pinaud E et al (2000) Alleles of the α1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure. Kidney Int 58:966–971

    Article  CAS  PubMed  Google Scholar 

  23. Bessette B, Guglielmi L, Cogne M, Denizot Y (2003) Nuclear factors, hs1,2 enhancer and IgA nephropathy. Kidney Int 63:767

    Article  PubMed  Google Scholar 

  24. Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82

    Article  PubMed  Google Scholar 

  25. Wang Z, Xie Z, Lu Q, Chang C, Zhou Z (2017) Beyond genetics: what causes type 1 diabetes. Clin Rev Allergy Immunol 52:273–286

    Article  CAS  PubMed  Google Scholar 

  26. Pociot F, Lernmark A (2016) Genetic risk factors for type 1 diabetes. Lancet 387:2331–2339

    Article  CAS  PubMed  Google Scholar 

  27. Crone J, Rami B, Huber WD, Granditsch G, Schober E (2003) Prevalence of celiac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 37:67–71

    Article  CAS  PubMed  Google Scholar 

  28. Shun CB, Donaghue KC, Phelan H, Twigg SM, Craig ME (2014) Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis. Diabet Med 31:126–135

    Article  CAS  PubMed  Google Scholar 

  29. Tolusso B, Frezza D, Mattioli C et al (2009) Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis 68:416–419

    Article  CAS  PubMed  Google Scholar 

  30. Liu J, Law RA, Koles PG, Saxe JC, Bottomley M, Sulentic CEW (2017) Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy. Dig Liver Dis 49:887–892

    Article  CAS  PubMed  Google Scholar 

  31. Le Noir S, Boyer F, Lecardeur S et al (2017) Functional anatomy of the immunoglobulin heavy chain 3 super-enhancer needs not only core enhancer elements but also their unique DNA context. Nucleic Acids Res 45:5829–5837

    Article  PubMed  PubMed Central  Google Scholar 

  32. Adlercreutz EH, Svensson J, Hansen D et al (2015) Prevalence of celiac disease autoimmunity in children with type 1 diabetes: regional variations across the Oresund strait between Denmark and southernmost Sweden. Pediatr Diabetes 16:504–509

    Article  CAS  PubMed  Google Scholar 

  33. Nistico L, Fagnani C, Coto I et al (2006) Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 55:803–808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Generali E, Ceribelli A, Stazi MA, Selmi C (2017) Lessons learned from twins in autoimmune and chronic inflammatory diseases. J Autoimmun 83:51–61

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Domenico Frezza.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was performed according to the ethical principles of the Helsinki Declaration of 1964, revised by the World Medical Organization in Edinburgh in 2000 and 2008 and was approved by the ethics committee of our hospital.

Informed consent

All participants provided written informed consent before the enrollment in the study.

Additional information

Managed by Massimo Porta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cianci, R., D’Addabbo, P., Gambassi, G. et al. Association between IgH enhancer hs1.2 and type 1 diabetes. Acta Diabetol 55, 443–448 (2018). https://doi.org/10.1007/s00592-018-1103-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1103-5

Keywords

Navigation